Impact of α1-adrenoceptor expression on contractile properties of vascular smooth muscle cells

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 293, Issue 3, 2007, Pages

  Gericke, Adrian ^a   Martinka, Peter ^a   Nazarenko, Irina ^a   Persson, Pontus B ^a   Patzak, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Alpha1; Gene transfection; Mayer waves; Nervous system; Sympathetic

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; PHENYLEPHRINE; POTASSIUM CHLORIDE; ADRENERGIC RECEPTOR ALPHA(1A); ADRENERGIC RECEPTOR ALPHA(1B); ADRENERGIC RECEPTOR ALPHA(1D); ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BLOCKING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; GENETIC TRANSFECTION; MALE; MEMBRANE DEPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; CELL SEPARATION; CYTOLOGY; GENE VECTOR; GENETICS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MUSCLE CONTRACTION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIBODIES, BLOCKING; CELL SEPARATION; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; TRANSFECTION;

EID: 34548433398     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00076.2007     Document Type: Article

References (48)

1. Angus JA, Ferrier CP, Sudhir K, Kaye DM, Jennings GL. Impaired contraction and relaxation in skin resistance arteries from patients with congestive heart failure. Cardiovasc Res 27: 204-210, 1993.
2. Bertram D, Barres C, Cheng Y, Julien C. Norepinephrine reuptake, baroreflex dynamics, and arterial pressure variability in rats. Am J Physiol Regul Integr Comp Physiol 279: R1257-R1267, 2000.
3. Bertram D, Barres C, Cuisinaud G, Julien C. The arterial baroreceptor reflex of the rat exhibits positive feedback properties at the frequency of Mayer waves. J Physiol 513: 251-261, 1998.
4. Chalothorn D, Mccune DF, Edelmann SE, Garcia-Cazarin ML, Tsujimoto G, Piascik MT. Differences in the cellular localization and agonist-mediated internalization properties of the alpha(1)-adrenoceptor subtypes. Mol Pharmacol 61: 1008-1016, 2002.
5. Chapuis B, Vidal-Petiot E, Orea V, Barres C, Julien C. Linear modelling analysis of baroreflex control of arterial pressure variability in rats. J Physiol 559: 639-649, 2004.
6. Cotecchia S, Schwinn DA, Randall RR, Lefkowitz RJ, Caron MG, Kobilka BK. Molecular cloning and expression of the cDNA for the hamster alpha-1-adrenergic receptor. Proc Natl Acad Sci USA 85: 7159-7163, 1988.
7. Dinenno FA, Dietz NM, Joyner MJ. Aging and forearm postjunctional alpha-adrenergic vasoconstriction in healthy men. Circulation 106: 1349-1354, 2002.
8. Eckhart AD, Yang NY, Xin XH, Faber JE. Characterization of the alpha(1B)-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle. Proc Natl Acad Sci USA 94: 9487-9492, 1997.
9. Eckhart AD, Zhu ZM, Arendshorst WJ, Faber JE. Oxygen modulates alpha(1B)-adrenergic receptor gene expression by arterial but not venous vascular smooth muscle. Am J Physiol Heart Circ Physiol 271: H1599-H1608, 1996.
10. Emonnot L, Bakhos C, Chapuis B, Orea V, Barres C, Julien C. Role of purinergic cotransmission in the sympathetic control of arterial pressure variability in conscious rats. Am J Physiol Regul Integr Comp Physiol 291: R736-R741, 2006.
11. Furlan R, Porta A, Costa F, Tank J, Baker L, Schiavi R, Robertson D, Malliani A, Mosqueda-Garcia R. Oscillatory patterns in sympathetic neural discharge and cardiovascular variables during orthostatic stimulus. Circulation 101: 886-892, 2000.
12. Gisbert R, Madrero Y, Sabino V, Noguera MA, Ivorra MD, D'Ocon P. Functional characterization of alpha 1-adrenoceptor subtypes in vascular tissues using different experimental approaches: a comparative study. Br J Pharmacol 138: 359-368, 2003.
13. Goldstein B, Toweill D, Lai S, Sonnenthal K, Kimberly B. Uncoupling of the autonomic and cardiovascular systems in acute brain injury. Am J Physiol Regul Integr Comp Physiol 275: R1287-R1292, 1998.
14. Gonzalez-Cabrera PJ, Gaivin RJ, Yun J, Ross SA, Papay RS, Mccune DF, Rorabaugh BR, Perez DM. Genetic profiling of alpha(1)-adrenergic receptor subtypes by oligonucleotide microarrays: Coupling to interleukin-6 secretion but differences in STAT3 phosphorylation and gp-130. Mol Pharmacol 63: 1104-1116, 2003.
15. Graham RM, Perez DM, Hwa J, Piascik MT. alpha(1)-Adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res 78: 737-749, 1996.
16. Grisk O, Stauss HM. Frequency modulation of mesenteric and renal vascular resistance. Am J Physiol Regul Integr Comp Physiol 282: R1468-R1476, 2002.
17. Gulli G, Fattor B, Marchesi M. Cross-spectral analysis of cardiovascular variables in supine diabetic patients. Clin Auton Res 15: 92-98, 2005.
18. Gurdal H, Cai GP, Johnson MD. Alpha(1)-adrenoceptor responsiveness in the aging aorta. Eur J Pharmacol 274: 117-123, 1995.
19. Gurdal H, Tilakaratne N, Brown RD, Fonseca M, Friedman E, Johnson MD. The expression of alpha(1) adrenoceptor subtypes changes with age in the rat aorta. J Pharmacol Exp Ther 275: 1656-1662, 1995.
20. Hogikyan RV, Supiano MA. Arterial alpha-adrenergic responsiveness is decreased and SNS activity is increased in older humans. Am J Physiol Endocrinol Metab 266: E717-E724, 1994.
21. Hosoda C, Koshimizu T, Tanoue A, Nasa Y, Oikawa R, Tomabechi T, Fukuda S, Shinoura H, Oshikawa S, Takeo S, Kitamura T, Cotecchia S, Tsujimoto G. Two alpha(1)-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation. Mol Pharmacol 67: 912-922, 2005.
22. Hrometz SL, Edelmann SE, Mccune DF, Olges JR, Hadley RW, Perez DM, Piascik MT. Expression of multiple alpha(1)-adrenoceptors on vascular smooth muscle: Correlation with the regulation of contraction. J Pharmacol Exp Ther 290: 452-463, 1999.
23. Hu ZW, Shi XY, Hoffman BB. Insulin and insulin-like growth factor I differentially induce alpha(1)-adrenergic receptor subtype expression in rat vascular smooth muscle cells. J Clin Invest 98: 1826-1834, 1996.
24. Julien C. The enigma of Mayer waves: Facts and models. Cardiovasc Res 70: 12-21, 2006.
25. Julien C, Malpas SC, Stauss HM. Sympathetic modulation of blood pressure variability. J Hypertens 19: 1707-1712, 2001.
26. Kalyankrishna S, Malik KU. Norepinephrine-induced stimulation of p38 mitogen-activated protein kinase is mediated by arachidonic acid metabolites generated by activation of cytosolic phospholipase A(2) in vascular smooth muscle cells. J Pharmacol Exp Ther 304: 761-772, 2003.
27. Kiuchi K, Vatner DE, Uemura N, Bigaud M, Hasebe N, Hempel DM, Graham RM, Vatner SF. Mechanisms of alpha-1-adrenergic vascular desensitization in conscious dogs. Circ Res 71: 1185-1199, 1992.
28. Kuster GM, Pimentel DR, Adachi T, Ido Y, Brenner DA, Cohen RA, Liao R, Siwik DA, Colucci WS. Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras. Circulation 111: 1192-1198, 2005.
29. Lomasney JW, Cotecchia S, Lorenz W, Leung WY, Schwinn DA, Yangfeng TL, Brownstein M, Lefkowitz RJ, Caron MG. Molecular cloning and expression of the cDNA for the alpha-1A-adrenergic receptor - the gene for which is located on human chromosome-5. J Biol Chem 266: 6365-6369, 1991.
30. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 84: 482-492, 1991.
31. Mueed I, Bains P, Zhang LL, MacLeod KM. Differential participation of protein kinase C and Rho kinase in alpha(1)-adrenoceptor mediated contraction in rat arteries. Can J Physiol Pharmacol 82: 895-902, 2004.
32. Pagani M, Montano N, Porta A, Malliani A, Abboud FM, Birkett C, Somers VK. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 95: 1441-1448, 1997.
33. Parati G, Saul JP, Di Rienzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. Hypertension 25: 1276-1286, 1995.
34. Persson PB. Modulation of cardiovascular control mechanisms and their interaction. Physiol Rev 76: 193-244, 1996.
35. Piascik MT, Perez DM. alpha(1)-adrenergic receptors: New insights and directions. J Pharmacol Exp Ther 298: 403-410, 2001.
36. Ponchon P, Elghozi JL. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats. Eur J Pharmacol 297: 61-70, 1996.
37. Radaelli A, Perlangeli S, Cerutti MC, Mircoli L, Mori I, Boselli L, Bonaita M, Terzoli L, Candotti G, Signorini G, Ferrari AU. Altered blood pressure variability in patients with congestive heart failure. J Hypertens 17: 1905-1910, 1999.
38. Rokosh DG, Simpson PC. Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 99: 9474-9479, 2002.
39. Salvi S. alpha(1)-adrenoreceptors and pulmonary hypertension. Chest 117: 1523-1524, 2000.
40. Schwinn DA, Lomasney JW, Lorenz W, Szklut PJ, Fremeau RT, Yangfeng TL, Caron MG, Lefkowitz RJ, Cotecchia S. Molecular cloning and expression of the cDNA for a novel alpha-1-adrenergic receptor subtype. J Biol Chem 265: 8183-8189, 1990.
41. Stauss HM, Godecke A, Mrowka R, Schrader J, Persson PB. Enhanced blood pressure variability in eNOS knockout mice. Hypertension 33: 1359-1363, 1999.
42. Stauss HM, Persson PB, Johnson AK, Kregel KC. Frequency-response characteristics of autonomic nervous system function in conscious rats. Am J Physiol Heart Circ Physiol 273: H786-H795, 1997.
43. Tanoue A, Koshimizu T, Tsujimoto G. Transgenic studies of alpha(1)-adrenergic receptor subtype function. Life Sci 71: 2207-2215, 2002.
44. van de Borne P, Montano N, Zimmerman B, Pagani M, Somers VK. Relationship between repeated measures of hemodynamics, muscle sympathetic nerve activity, and their spectral oscillations. Circulation 96: 4326-4332, 1997.
45. Williams NG, Zhong H, Minneman KP. Differential coupling of alpha1-, alpha2-, and beta-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells. J Biol Chem 273: 24624-24632, 1998.
46. Xiao L, Pimentel DR, Wang J, Singh K, Colucci WS, Sawyer DB. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol Cell Physiol 282: C926-C934, 2002.
47. Yang M, Ruan J, Voller M, Schalken J, Michel MC. Differential regulation of human alpha(1)-adrenoceptor subtypes. Naunyn-Schmiedebergs Arch Pharmacol 359: 439-446, 1999.
48. Yeoh M, Brock JA. Rho kinase inhibitors reduce neurally evoked contraction of the rat tail artery in vitro. Br J Pharmacol 146: 854-861, 2005.